Skip to content
OpenCapital
Get started

MapLight Therapeutics, Inc. MPLT Q3 2025 earnings

Reported December 4, 2025 · Before market open

Diluted EPS-$37.18Miss by $35.46
EPS estimate-$1.72

Next report

Aug 13, 2026 (in a month)
EPS estimate-$1.37

Financials

Q3 2025

Income statement

See full
Operating income-$31.5M-50.8%
Net income-$29.4M-54.7%
EPS (diluted)-$37.18-48.2%

Balance sheet

See full
Cash & equivalents$64.1M—
Total debt$6.0M—
Total equity-$274.2M-59.1%
Total assets$257.2M—

Versus estimates

Diluted EPS

Q4 2025-$1.34Miss by $0.38
Q3 2025-$37.18Miss by $35.46

Ask the moment MapLight Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did MapLight Therapeutics, Inc. report Q3 2025 earnings?
MapLight Therapeutics, Inc. (MPLT) reported Q3 2025 earnings on December 4, 2025 before market open.
What were MapLight Therapeutics, Inc. 's Q3 2025 revenue and EPS?
MapLight Therapeutics, Inc. reported diluted EPS of $-37.18 for Q3 2025.
Did MapLight Therapeutics, Inc. beat estimates in Q3 2025?
EPS missed the consensus estimate of $-1.72 by $35.46.
Where can I find MapLight Therapeutics, Inc. 's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-307450) and the 10-Q periodic report (0001193125-25-307453) directly on SEC EDGAR. The filing index links above go to sec.gov.